|
42
|
126
|
4z1sA |
Crystal structure of the first bromodomain of human brd4 with benzotriazolo-diazepine scaffold |
|
35
|
100
|
4yyiA |
Crystal structure of brd9 bromodomain bound to an acetylated peptide |
|
54
|
184
|
4yabA |
Crystal structure of trim24 phd-bromodomain complexed with 1-methyl-5-(2-methyl-1 3-thiazol-4-yl)-2 3-dihydro-1h-indol-2-one (1) |
|
44
|
127
|
4f3iA |
Crystal structure of the first bromodomain of human brd4 in complex with ms417 inhibitor |
|
40
|
106
|
4qnsA |
Crystal structure of bromodomain from plasmodium faciparum gcn5, pf3d7_0823300 |
|
43
|
124
|
4e96A |
Crystal structure of the first bromodomain of human brd4 in complex with the inhibitor pfi-1 |
|
45
|
124
|
4donA |
Brd4 bromodomain 1 complex with a fragment 3,4-dihydro-3-methyl-2(1h)-quinazolinon |
|
42
|
115
|
4cupA |
Crystal structure of human baz2b in complex with fragment-1 n09421 |
|
40
|
115
|
4cusA |
Crystal structure of human baz2b in complex with fragment-4 n09496 |
|
40
|
115
|
4cuuA |
Crystal structure of human baz2b in complex with fragment-6 n09645 |
|
39
|
115
|
4cutA |
Crystal structure of human baz2b in complex with fragment-5 n09428 |
|
39
|
115
|
4cuqA |
Crystal structure of human baz2b in complex with fragment-2 n09594 |
|
43
|
126
|
4c66A |
Discovery of epigenetic regulator i-bet762: lead optimization to afford a clinical candidate inhibitor of the bet bromodomains |
|
43
|
127
|
4cfkA |
N-terminal bromodomain of human brd4 with ly294002 |
|
42
|
127
|
4clbA |
N-terminal bromodomain of human brd4 with ibet-295 |
|
44
|
127
|
4bw2A |
The first bromodomain of human brd4 in complex with 3,5 dimethylisoxaxole ligand |
|
45
|
127
|
4cflA |
N-terminal bromodomain of human brd4 with ly303511 |
|
44
|
127
|
4bw4A |
The first bromodomain of human brd4 in complex with 3,5 dimethylisoxaxole ligand |
|
45
|
127
|
4bw1A |
The first bromodomain of human brd4 in complex with 3,5 dimethylisoxaxole ligand |
|
41
|
127
|
4bw3A |
The first bromodomain of human brd4 in complex with 3,5 dimethylisoxaxole ligand |
|
44
|
127
|
4c67A |
Discovery of epigenetic regulator i-bet762: lead optimization to afford a clinical candidate inhibitor of the bet bromodomains |
|
44
|
127
|
4bjxA |
N-terminal bromodomain of human brd4 with gsk1324726a (i-bet726) |
|
161
|
563
|
4bhwA |
Structural basis for autoinhibition of the acetyltransferase activity of p300 |
|
39
|
112
|
4a9hA |
N-terminal bromodomain of human brd2 with 1-(2-methyl-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one |
|
38
|
112
|
4aknA |
N-terminal bromodomain of human brd2 with tbutyl-phenyl-amino- dimethyl-oxazolyl-quinoline-carboxylic acid |
|
42
|
115
|
4a9oA |
N-terminal bromodomain of human brd2 with 5 ethyl-3-methyl-4-phenyl-1, 2-oxazole |
|
37
|
110
|
4a9iA |
N-terminal bromodomain of human brd2 with 3-methyl-1,2,3,4- tetrahydroquinazolin-2-one |
|
37
|
112
|
4a9mA |
N-terminal bromodomain of human brd2 with n-cyclopentyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylbenzene-1-sulfonamide |
|
39
|
115
|
4a9kA |
Bromodomain of human crebbp with n-(4-hydroxyphenyl)acetamide |
|
37
|
108
|
4a9fA |
N-terminal bromodomain of human brd2 with 1-methylpyrrolidin-2-one |
|
38
|
112
|
4a9jA |
N-terminal bromodomain of human brd2 with n-(4-hydroxyphenyl) acetamide |
|
38
|
112
|
4a9nA |
N-terminal bromodomain of human brd2 with n-cyclopropyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylbenzene-1-sulfonamide |
|
43
|
127
|
3zyuA |
Crystal structure of the first bromodomain of human brd4 in complex with i-bet151(gsk1210151a) |
|
42
|
126
|
4a9lA |
N-terminal bromodomain of human brd4 with 1,3-dimethyl-6-(morpholine- 4-sulfonyl)-1,2,3,4-tetrahydroquinazolin-2-one |
|
35
|
108
|
4alhA |
N-terminal bromodomain of human brd2 with 3,5 dimethyl-4-phenyl-1,2- oxazole |
|
38
|
112
|
4a9eA |
N-terminal bromodomain of human brd2 with 3-methyl-1,2,3,4- tetrahydroquinazolin-2-one |
|
37
|
118
|
4algA |
N-terminal bromodomain of human brd2 with ibet-151 |
|
38
|
124
|
3uw9A |
Crystal structure of the first bromodomain of human brd4 in complex with a diacetylated histone 4 peptide (h4k8ack12ac) |
|
45
|
127
|
3uvxA |
Crystal structure of the first bromodomain of human brd4 in complex with a diacetylated histone 4 peptide (h4k12ack16ac) |
|
46
|
122
|
3uvdA |
Crystal structure of the bromodomain of human transcription activator brg1 (smarca4) in complex with n-methyl-2-pyrrolidone |
|
48
|
125
|
3uv4A |
Crystal structure of the second bromodomain of human transcription initiation factor tfiid subunit 1 (taf1) |
|
44
|
127
|
3uvwA |
Crystal structure of the first bromodomain of human brd4 in complex with a diacetylated histone 4 peptide (h4k5ack8ac) |
|
50
|
119
|
3uv2A |
Crystal structure of the bromodomain of human nucleosome-remodeling factor subunit bptf |
|
100
|
255
|
3uv5A |
Crystal structure of the tandem bromodomains of human transcription initiation factor tfiid subunit 1 (taf1) |
|
36
|
109
|
3uvyA |
Crystal structure of the first bromodomain of human brd4 in complex with a diacetylated histone 4 peptide (h4k16ack20ac) |
|
44
|
127
|
3u5lA |
Crystal structure of the first bromodomain of human brd4 in complex with a benzo-triazepine ligand (bzt-7) |
|
54
|
205
|
3u5oA |
Crystal structure of the complex of trim33 phd-bromo and h3(1-22)k9me3k14ack18ac histone peptide |
|
49
|
203
|
3u5mA |
Crystal structure of trim33 phd-bromo in the free state |
|
41
|
126
|
3u5kA |
Crystal structure of the first bromodomain of human brd4 in complex with midazolam |
|
42
|
119
|
3tlpA |
Crystal structure of the fourth bromodomain of human poly-bromodomain containing protein 1 (pb1) |
